Insider plans sale of APLS common shares

APLS insider Timothy E. Sullivan has filed a notice of proposed sale of restricted stock under Rule 144.

Rhea-AI Filing Summary

APLS insider Timothy E. Sullivan has filed a notice of proposed sale of restricted stock under Rule 144. The planned transaction covers 3,856 shares of common stock to be sold through Fidelity Brokerage Services LLC on or about 01/13/2026 on the NASDAQ, with an aggregate market value of 85,553.84 based on the figures disclosed.

The shares to be sold were acquired from the issuer on 01/12/2026 through restricted stock vesting as compensation, with full amount of 3,856 shares acquired and paid on that date. Over the prior three months, Sullivan sold 10,000 common shares on 10/21/2025 for gross proceeds of 280,300.00.

By signing the notice, the seller represents that he does not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed and acknowledges that intentional misstatements or omissions can constitute federal criminal violations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the APLS Form 144 filing disclose?

It discloses that insider Timothy E. Sullivan plans to sell 3,856 shares of APLS common stock under Rule 144 through Fidelity Brokerage Services LLC on or about 01/13/2026 on the NASDAQ.

How many APLS shares are covered by this planned Rule 144 sale?

The filing states that 3,856 common shares are proposed to be sold, with an aggregate market value of 85,553.84 based on the figures disclosed.

How were the APLS shares being sold acquired by the insider?

According to the filing, the 3,856 shares were acquired on 01/12/2026 directly from the issuer via restricted stock vesting, categorized as compensation.

What prior APLS share sales by this person are reported in the last 3 months?

The document reports that 10,000 common shares were sold on 10/21/2025 by Timothy E. Sullivan for 280,300.00 in gross proceeds.

What is the total number of APLS shares outstanding mentioned in the filing?

The Rule 144 notice lists 126,525,218 common shares as the number of shares or other units outstanding for the issuer.

What representation does the insider make in this APLS Rule 144 notice?

By signing, the insider represents that he does not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed and is reminded that intentional misstatements or omissions can be federal criminal violations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/13/2026 - 03:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001707000
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Apellis Pharmaceuticals, Inc.
SEC File Number	001-38276
Address of Issuer	100 FIFTH AVENUE WALTHAM MASSACHUSETTS 02451
Phone	617-977-5700
Name of Person for Whose Account the Securities are To Be Sold	Sullivan Timothy Eugene
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3856	85553.84	126525218	01/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/12/2026	Restricted Stock Vesting	Issuer			3856	01/12/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Timothy E. Sullivan 100 Fifth Avenue Waltham MA 02451	Common	10/21/2025	10000	280300.00

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Timothy Sullivan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)